Han and Ma indicated that HULC upregulated the expression of myeloid cell leukemia 1 (MCL1) by sponging miR-150-5p, thereby enhancing the resistance of CML cells to imatinib [18]. Here, MCL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.